Vascular access for hemodialysis: Current perspectives

International Journal of Nephrology and Renovascular Disease

Volumn 7, Issue , 2014, Pages 281-294

  Santoro, Domenico ^a   Benedetto, Filippo ^a   Mondello, Placido ^a   Pipitò, Narayana ^a   Barillà, David ^a   Spinelli, Francesco ^a   Ricciardi, Carlo Alberto ^a   Cernaro, Valeria ^a   Buemi, Michele ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Arteriovenous fistula; Central venous catheter; Infection; Prosthetic grafts

Indexed keywords

ARTERIOVENOUS FISTULA; ARTERIOVENOUS SHUNT; CENTRAL VENOUS CATHETER; DEFIBRILLATOR; DIALYSIS CATHETER; FEMORAL VEIN; HEMODIALYSIS; HOSPITALIZATION; HUMAN; IMPLANTED HEART PACEMAKER; INTERNAL JUGULAR VEIN; LONGEVITY; MORBIDITY; MORTALITY; PROSTHESIS MATERIAL; REVIEW; RISK BENEFIT ANALYSIS; SUBCLAVIAN VEIN; SUPERIOR CAVA VEIN; VASCULAR ACCESS;

EID: 84904174571     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S46643     Document Type: Review

References (90)

1. Vascular Access 2006 Work Group. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006; 48 Suppl 1: S176-S247.
2. Fissell RB, Fuller DS, Morgenstern H, etal. Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS. J Vasc Access. 2013; 14(3): 264-272.
3. Malovrh M. Native arteriovenous fistula: preoperative evaluation. Am J Kidney Dis. 2002; 39(6): 1218-1225.
4. Santoro D, Savica V, Bellinghieri G. Vascular access for hemodialysis and cardiovascular complications. Minerva Urol Nefrol. 2010; 62(1): 81-85.
5. Mendes RR, Farber MA, Marston WA, Dinwiddie LC, Keagy BA, Burnham SJ. Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vasc Surg. 2002; 36(3): 460-463.
6. National Kidney Foundation, Inc. K/DOQI Guidelines-Updates 2006. New York: National Kidney Foundation, Inc; 2001. Available from: http: //www.kidney.org/PROFESSIONALS/kdoqi/guideline_upHD_PD_VA/index.htm. Accessed June 5, 2014.
7. Leapman SB, Boyle M, Pescovitz MD, Milgrom ML, Jindal RM, Filo RS. The arteriovenous fistula for hemodialysis access: gold standard or archaic relic? Am Surg. 1996; 62(8): 652-656.
8. Wolowczyk L, Williams AJ, Donovan KL, Gibbons CP. The snuffbox arteriovenous fistula for vascular access. Eur J Vasc Endovasc Surg. 2000; 19(1): 70-76.
9. Korkut AK, Kosem M. Superficialization of the basilic vein technique in brachiobasilic arteriovenous fistula: surgical experience of 350 cases during 4 years period. Ann Vasc Surg. 2010; 24(6): 762-767.
10. Livingston CK, Potts JR 3rd. Upper arm arteriovenous fistulas as a reliable access alternative for patients requiring chronic hemodialysis. Am Surg. 1999; 65(11): 1038-1042.
11. Bender MH, Bruyninckx CM, Gerlag PG. The brachiocephalic elbow fistula: a useful alternative angioaccess for permanent hemodialysis. J Vasc Surg. 1994; 20(5): 808-813.
12. US Renal Data System: USRDS 2005 Annual Data Report: Atlas of Endstage Renal Disease in the United States. Incidence and Prevalence; Patient Characteristics, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005.
13. Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006; 17(11): 3204-3212.
14. Dember LM, Imrey PB, Beck GJ, etal; Hemodialysis Fistula Maturation Study Group. Objectives and design of the hemodialysis fistula maturation study. Am J Kidney Dis. 2014; 63(1): 104-112.
15. Polo JR, Vázquez R, Polo J, Sanabia J, Rueda JA, Lopez-Baena JA. Brachiocephalic jump graft fistula: an alternative for dialysis use of elbow crease veins. Am J Kidney Dis. 1999; 33(5): 904-909.
16. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000; 57(2): 639-645.
17. Applebaum H, Shashikumar VL, Somers LA, etal. Improved hemodialysis access in children. J Pediatr Surg. 1980; 15: 764-769.
18. Davidson I, Gallieni M, Saxena R, Dolmatch B. A patient centered decision making dialysis access algorithm. J Vasc Access. 2007; 8: 59-68.
19. National Kidney Foundation. K/DOQI Clinical Practice Guidelines For Vascular Access, 2000. Am J Kidney Dis. 2001; 37(Suppl 1): S137-S181.
20. Pisoni RL, Young EW, Dykstra DM, etal. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002; 61: 305-316.
21. Sidawy AN, Gray R, Besarab A, etal. Recommended standards for report dealing with arteriovenous hemodialysis accesses. J Vasc Surg. 2002; 35: 603-610.
22. Ethier JH, Lindsay RM, Barre PE, Kappel JE, Carlisle EJ, Common A. Clinical practice guidelines for vascular access. Canadian Society of Nephrology. J Am Soc Nephrol. 1999; 10(Suppl 13): S297-S305.
23. Golledge J, Smith CJ, Emery J, Farrington K, Thompson HH. Outcome of primary radiocephalic fistula for haemodialysis. Br J Surg. 1999; 86: 211-216.
24. Murphy GJ, White SA, Knight AJ, Doughman T, Nicholson ML. Long-term results of arteriovenous fistulas using transposed autologous basilic vein. Br J Surg. 2000; 87: 819-823.
25. Murphy GJ, White SA, Nicholson ML. Vascular access for haemodialysis. Br J Surg. 2000; 87(10): 1300-1315.
26. Robbin ML, Gallichio MH, Deierhoi MH, Young CJ, Weber TM, Allon M. US vascular mapping before hemodialysis access placement. Radiology. 2000; 217: 83-88.
27. Silva MB Jr, Hobson RW 2nd, Pappas PJ, etal. A strategy for increasing use of autogenous hemodialysis acces procedures: impact of preoperative noninvasive evaluation. J Vasc Surg. 1998; 27: 302-307.
28. Benedetto F, Carella G, Lentini S, etal. Use of bovine mesenteric vein in rescue vascular access surgery. J Vasc Access. 2010; 11(2): 112-114.
29. Khadra MH, Dwyer AJ, Thompson JF. Advantages of polytetrafluoroethylene arteriovenous loops in the thigh for hemodialysis access. Am J Surg. 1997; 173: 280-283.
30. Salimi J. Patency rate and complications of vascular access grafts for hemodialysis in lower extremities. Saudi J Kidney Dis Transpl. 2008; 19: 929-932.
31. Slater ND, Raftery AT. An evaluation of expanded poly-tetrafluoroethylene (PTFE) loop grafts in the thigh as vascular access for haemodialysis in patients with access problems. Ann R Coll Surg Engl. 1988; 70: 243-245.
32. Englesbe MJ, Al-Holou WN, Moyer AT, etal. Single centre review of femoral arteriovenous grafts for hemodialysis. World J Surg. 2006; 30: 171-175.
33. Rizzuti RP, Hale JC, Burkart TE. Extended patency of expanded polytetrafluoroethylene grafts for vascular access using optimal configuration and revisions. Surg Gynecol Obstet. 1988; 166: 23-27.
34. Roy-Chaudhury P, Kelly BS, Miller MA, etal. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int. 2001; 59: 2325-2334.
35. May RE, Himmelfarb J, Yenicesu M, etal. Predictive measures of vascular access thrombosis: a prospective study. Kidney Int. 1997; 52: 1656-1662.
36. Staalsen NH, Ulrich M, Winther J, Pedersen EM, How T, Nygaard H. The anastomosis angle does change the flow fields at vascular end-to-side anastomoses in vivo. J Vasc Surg. 1995; 21: 460-471.
37. Kaufman JS. Antithrombotic agents and the prevention of access thrombosis. Semin Dial. 2000; 13(1): 40-46.
38. Lok CE, Moist L, Hemmelgarn BR, etal; Fish Oil Inhibition of Stenosis in Hemodialysis Grafts (FISH) Study Group. Effect of fish oil supplementation on graft patency and cardiovascular events among patients with new synthetic arteriovenous hemodialysis grafts: a randomized controlled trial. JAMA. 2012; 307(17): 1809-1816.
39. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol. 2002; 23: 716-720.
40. Kaplowitz LG, Comstock JA, Landwehr DM, Dalton HP, Mayhall CG. Prospective study of microbial colonization of the nose and skin and infection of the vascular access site in hemodialysis patients. J Clin Microbiol. 1988; 26: 1257-1262.
41. Ryan SV, Calligaro KD, Scharff J, Dougherty MJ. Management of infected prosthetic dialysis arteriovenous grafts. J Vasc Surg. 2004; 39: 73-78.
42. National Kidney Foundation, Inc. KDOQI. Guideline 27: Treatment do pseudoaneurysm of dialysis AV grafts (NKF KDOQI GUIDELINES 2000). New York: National Kidney Foundation, Inc; 2001. Available from: https: //www.kidney.org/professionals/kdoqi/guidelines_updates/doqiupva_iv.html#17. Accessed June 5, 2014.
43. Shemesh D, Goldin I, Zaghal I, Berelowitz D, Verstandig AG, Olsha O. Stent graft treatment for hemodialysis access aneurysms. J Vasc Surg. 2011; 54: 1088-1094.
44. Shah AS, Valdes J, Charlton-Ouw KM, etal. Endovascular treatment of hemodialysis access pseudoaneurysms. J Vasc Surg. 2012; 55: 1058-1062.
45. Bellinghieri G, Ricciardi B, Costantino G, etal. Exhaustion of vascular endowment in hemodialysis: proposal for a permanent inlet access. Int J Artif Organs. 1998; 21(4): 201-204.
46. National Institute for Clinical Excellence. Guidance on the use of ultrasound locating devices for placing central venous catheters. Technology Appraisal Guidance No 49. London: National Institute for Clinical Excellence; 2002. Available from: http: //www.nice.org.uk/nicemedia/pdf/Ultrasound_49_guidance.pdf. Accessed June 5, 2014.
47. Dolla D, Cavatorta F, Galli S, Zollo A, Ervo S. Anatomical variations of the internal jugular vein in non-uremic outpatients. J Vasc Access. 2001; 2(2): 60-63.
48. Lamperti M, Bodenham AR, Pittiruti M, etal. International evidence-based recommendations on ultrasound-guided vascular access. Intensive Care Med. 2012; 38(7): 1105-1117.
49. Karakitos D, Labropoulos N, De Groot E, etal. Real-time ultra-sound guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care. 2006; 10(6): R162.
50. Clenaghan S, McLaughlin RE, Martyn C, McGovern S, Bowra J. Relationship between Trendelenburg tilt and internal jugular vein diameter. Emerg Med J. 2005; 22: 867-868.
51. Graham AS, Ozment C, Tegtmeyer K, Lai S, Braner DA. Videos in clinical medicine. Central venous catheterization. N Engl J Med. 2007; 356(21): e21.
52. Khatri VP, Wagner-Sevy S, Espinosa MH, Fisher JB. The internal jugular vein maintains its regional anatomy and patency after carotid endarterectomy: a prospective study. Ann Surg. 2001; 233: 282-286.
53. Rossi UG, Rigamonti P, Tichà V, etal. Percutaneous ultrasound-guided central venous catheters: the lateral in-plane technique for internal jugular vein access. J Vasc Access. 2014; 15(1): 56-60.
54. Jankovic Z, Boon A, Prasad R. Fatal haemothorax following large-bore percutaneous cannulation before liver transplantation. Br J Anaesth. 2005; 95(4): 472-476.
55. Yoffa D. Supraclavicular subclavian venepuncture and catheterization. Lancet. 1965; 2: 614-617.
56. Hameeteman M, Bode AS, Peppelenbosch AG, van der Sande FM, Tordoir JH. Ultrasound-guided central venous catheter placement by surgical trainees: a safe procedure? Vasc Access. 2010; 11(4): 288-292.
57. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med. 2003; 348(12): 1123-1133.
58. Kusminsky RE. Complications of central venous catheterization. J Am Coll Surg. 2007; 204(4): 681-696.
59. Bishop L, Dougherty L, Bodenham A, etal. Guidelines on the insertion and management of central venous access devices in adults. Int J Lab Hematol. 2007; 29(4): 261-278.
60. Merrer J, De Jonghe B, Golliot F, etal. Complications of femoral and subclavian venous catheterization in critically ill patients. JAMA. 2001; 286: 700-707.
61. Santoro D, Postorino A, Condemi CG, etal. Tunneled dialysis catheter and pacemaker leads determining superior vena cava syndrome. J Vasc Access. 2011; 12(3): 271-272.
62. Swindle MM, Nolan T, Jacobson A, Wolf P, Dalton MJ, Smith AC. Vascular access port (VAP) usage in large animal species. Contemp Top Lab Anim Sci. 2005; 44(3): 7-17.
63. Colas A, Curtis J. Silicone biomaterials-history and chemistry. In: Rutner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science: an Introduction to Materials in Medicine. Boston: Elsevier Academic Press; 2004: 80-86.
64. Colas A, Curtis J. Medical applications of silicones. In: Rutner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials Science: an Introduction to Materials in Medicine. Boston: Elsevier Academic Press; 2004: 697-707.
65. Brown JM. Polyurethane and silicone: myths and misconceptions. J Intraven Nurs. 1995; 18(3): 120-122.
66. Cohen AB, Dagli M, Stavropoulos SW Jr, etal. Silicone and polyurethane tunneled infusion catheters: a comparison of durability and breakage rates. J Vasc Interv Radiol. 2011; 22(5): 638-641.
67. Savader S, Trerotola S, editors. Venous Interventional Radiology with Clinical Perspectives. 2nd edition. New York: Thieme Medical Publisher, Inc.; 2000.
68. Rupp ME, Lisco SJ, Lipsett PA, etal. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial. Ann Intern Med. 2005; 143(8): 570-580.
69. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection with an antiseptic-impregnated catheter: a randomized, controlled trial. Ann Intern Med. 1997; 127(4): 257-266.
70. McCann M, Moore ZEH. Interventions for preventing infectious complications in haemodialysis patients with central venous catheters. Cochrane Database Syst Rev. 2010; (1): CD006894.
71. Astor BC, Eustace JA, Powe NR, Klag MJ, Fink NE, Coresh J; CHOICE Study. Type of vascular access and survival among incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005; 16(5): 1449-1455.
72. Mermel LA, Allon M, Bouza E, etal. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009; 49(1): 1-45.
73. Engemann JJ, Friedman JY, Reed SD, etal. Clinical outcomes and cost due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol. 2005; 26(6): 534-539.
74. Maki DG, Kluger DM, Crinich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006; 81(9): 1159-1171.
75. CDC (Centers for Disease Control and Prevention). Vital signs: central line-associated bloodstream infections-United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011; 60: 243-248.
76. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. I. Pathogenesis and short-term devices. Clin Infect Dis. 2002; 34(9): 1232-1242.
77. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39(3): 309-317.
78. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med. 2005; 142(6): 451-466.
79. Blot F, Schmidt E, Nitenberg G, etal. Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol. 1998; 36(1): 105-109.
80. Allon M. Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis. 2009; 54(1): 13-17.
81. National Institute for Health and Care Excellence. CG139: Infection: prevention and control of healthcare-associated infections in primary and community care. Available from: http: //publications.nice.org.uk/infection-cg139/other-versions-of-this-guideline#full-guideline. Accessed May 3, 2014.
82. Vanholder R, Canaud B, Fluck R, etal. Diagnosis, prevention and treatment of haemodialysis catheter-related blood stream infections (CRBSI): a position statement of European Renal Best Practice (ERBP). NDT Plus. 2010; 3(3): 234-246.
83. Messing B, Peitra-Cohen S, Debure A, Beliah M, Bernier JJ. Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 1988; 12(2): 185-189.
84. CDC. gov [homepage on the Internet]. CDC Approach to BSI Prevention in Dialysis Facilities. Available from: http: //www.cdc.gov/dialysis/PDFs/Dialysis-Core-Interventions-5_10_13.pdf. Accessed December 8, 2013.
85. Milburn JA, Cassar K, Ford I, Fluck N, Brittenden J. Prothrombotic changes in platelet, endothelial and coagulation function following hemodialysis. Int J Artif Organs. 2011; 34(3): 280-287.
86. Milburn JA, Ford I, Mutch NJ, Fluck N, Brittenden J. Thrombin-anti-thrombin levels and patency of arterio-venous fistula in patients undergoing haemodialysis compared to healthy volunteers: a prospective analysis. PLoS One. 2013; 8(7): e67799.
87. NKF-KDOQI. Clinical practice guidelines for vascular access. Am J Kidney Dis. 2006; 48(Suppl 1): S248-S272.
88. Tordoir J, Canaud B, Haage P, etal. European best practice guidelines (EBPG) on vascular access. Nephrol Dial Transplant. 2007; 22(Suppl 2): ii88-ii117.
89. Ravani P, Palmer SC, Oliver MJ, etal. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013; 24: 465-473.
90. Grubbs V, Wasse H, Vittinghoff E, etal. Health status as a potential mediator of the association between hemodialysis vascular access and mortality. Nephrol Dial Transplant. 2014; 29: 892-898.